cyclosporine and Liver Diseases, Alcoholic

cyclosporine has been researched along with Liver Diseases, Alcoholic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, J; Cederbaum, AI1
Dudley, T; Haydon, G; Mutimer, D; Nightingale, P; Oo, YH1
Kaplan, MM; Pedrosa, MC; Rohrer, RM1
Harrison, D; Holland, BK; Holman, MJ; Ippolito, T; Koneru, B; Leevy, CB; Rizwan, M1
Cahill, A; Hoek, JB; Marcineviciute, A; Pastorino, JG1

Other Studies

5 other study(ies) available for cyclosporine and Liver Diseases, Alcoholic

ArticleYear
Overexpression of CYP2E1 in mitochondria sensitizes HepG2 cells to the toxicity caused by depletion of glutathione.
    The Journal of biological chemistry, 2006, Feb-24, Volume: 281, Issue:8

    Topics: Aldehydes; Animals; Antioxidants; Blotting, Western; Buthionine Sulfoximine; Catalysis; Cell Line; Cell Survival; Cyclosporine; Cytochrome P-450 CYP2E1; DNA, Complementary; Endoplasmic Reticulum; Ethanol; Flow Cytometry; Glutathione; Humans; Liver; Liver Diseases, Alcoholic; Male; Membrane Potentials; Microscopy, Confocal; Mitochondria; Mitochondria, Liver; Oxidative Stress; Plasmids; Rats; Rats, Sprague-Dawley; Subcellular Fractions; Time Factors; Transfection; Tyrosine

2006
Tacrolimus and cyclosporin doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2008, Volume: 14, Issue:1

    Topics: Adult; Aged; Biopsy; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Diseases, Alcoholic; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Tacrolimus; Treatment Outcome

2008
Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Clinical transplantation, 1995, Volume: 9, Issue:4

    Topics: Adolescent; Adult; Aged; Azathioprine; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cholangitis, Sclerosing; Cushing Syndrome; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Incidence; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases, Alcoholic; Liver Failure, Acute; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Prednisone

1995
Blood transfusions in liver recipients: a conundrum or a clear benefit in the cyclosporine/tacrolimus era?
    Transplantation, 1997, Jun-15, Volume: 63, Issue:11

    Topics: Adult; Blood Transfusion; Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Intraoperative Period; Liver Diseases, Alcoholic; Liver Failure; Liver Transplantation; Male; Middle Aged; Tacrolimus; Time Factors

1997
Potentiation by chronic ethanol treatment of the mitochondrial permeability transition.
    Biochemical and biophysical research communications, 1999, Nov-19, Volume: 265, Issue:2

    Topics: Alcoholism; Animals; Apoptosis; bcl-2-Associated X Protein; Calcium; Ceramides; Cyclosporine; Ethanol; Gangliosides; In Vitro Techniques; Liver Diseases, Alcoholic; Male; Mitochondria, Liver; Mitochondrial Swelling; Necrosis; Permeability; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley

1999